Global and United States Tumor Radiofrequency Ablation Market Report & Forecast 2023-2028

Report ID: 1823502 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Tumor Radiofrequency Ablation Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Tumor Radiofrequency Ablation Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Tumor Radiofrequency Ablation Market Size for the Year 2017-2028
        1.2.2 Global Tumor Radiofrequency Ablation Market Size for the Year 2017-2028
    1.3 Tumor Radiofrequency Ablation Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Tumor Radiofrequency Ablation in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Tumor Radiofrequency Ablation Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Tumor Radiofrequency Ablation Market Dynamics
        1.4.1 Tumor Radiofrequency Ablation Industry Trends
        1.4.2 Tumor Radiofrequency Ablation Market Drivers
        1.4.3 Tumor Radiofrequency Ablation Market Challenges
        1.4.4 Tumor Radiofrequency Ablation Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Tumor Radiofrequency Ablation by Type
    2.1 Tumor Radiofrequency Ablation Market Segment by Type
        2.1.1 Lung Cancer
        2.1.2 Kidney Cancer
        2.1.3 Breast Cancer
        2.1.4 Prostate Cancer
        2.1.5 Liver Cancer
        2.1.6 Others
    2.2 Global Tumor Radiofrequency Ablation Market Size by Type (2017, 2022 & 2028)
    2.3 Global Tumor Radiofrequency Ablation Market Size by Type (2017-2028)
    2.4 United States Tumor Radiofrequency Ablation Market Size by Type (2017, 2022 & 2028)
    2.5 United States Tumor Radiofrequency Ablation Market Size by Type (2017-2028)
3 Tumor Radiofrequency Ablation by Application
    3.1 Tumor Radiofrequency Ablation Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Cancer Specialty Clinics
        3.1.3 Others
    3.2 Global Tumor Radiofrequency Ablation Market Size by Application (2017, 2022 & 2028)
    3.3 Global Tumor Radiofrequency Ablation Market Size by Application (2017-2028)
    3.4 United States Tumor Radiofrequency Ablation Market Size by Application (2017, 2022 & 2028)
    3.5 United States Tumor Radiofrequency Ablation Market Size by Application (2017-2028)
4 Global Tumor Radiofrequency Ablation Competitor Landscape by Company
    4.1 Global Tumor Radiofrequency Ablation Market Size by Company
        4.1.1 Top Global Tumor Radiofrequency Ablation Companies Ranked by Revenue (2021)
        4.1.2 Global Tumor Radiofrequency Ablation Revenue by Player (2017-2022)
    4.2 Global Tumor Radiofrequency Ablation Concentration Ratio (CR)
        4.2.1 Tumor Radiofrequency Ablation Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Tumor Radiofrequency Ablation in 2021
        4.2.3 Global Tumor Radiofrequency Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Tumor Radiofrequency Ablation Headquarters, Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Tumor Radiofrequency Ablation Headquarters and Area Served
        4.3.2 Global Tumor Radiofrequency Ablation Companies Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Tumor Radiofrequency Ablation Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Tumor Radiofrequency Ablation Market Size by Company
        4.5.1 Top Tumor Radiofrequency Ablation Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Tumor Radiofrequency Ablation Revenue by Players (2020, 2021 & 2022)
5 Global Tumor Radiofrequency Ablation Market Size by Region
    5.1 Global Tumor Radiofrequency Ablation Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Tumor Radiofrequency Ablation Market Size by Region (2017-2028)
        5.2.1 Global Tumor Radiofrequency Ablation Market Size by Region: 2017-2022
        5.2.2 Global Tumor Radiofrequency Ablation Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Tumor Radiofrequency Ablation Market Size YoY Growth 2017-2028
        6.1.2 North America Tumor Radiofrequency Ablation Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Tumor Radiofrequency Ablation Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Tumor Radiofrequency Ablation Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Tumor Radiofrequency Ablation Market Size YoY Growth 2017-2028
        6.3.2 Europe Tumor Radiofrequency Ablation Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Tumor Radiofrequency Ablation Market Size YoY Growth 2017-2028
        6.4.2 Latin America Tumor Radiofrequency Ablation Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Tumor Radiofrequency Ablation Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Tumor Radiofrequency Ablation Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Boston Scientific
        7.1.1 Boston Scientific Company Details
        7.1.2 Boston Scientific Business Overview
        7.1.3 Boston Scientific Tumor Radiofrequency Ablation Introduction
        7.1.4 Boston Scientific Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.1.5 Boston Scientific Recent Development
    7.2 Diros Technology
        7.2.1 Diros Technology Company Details
        7.2.2 Diros Technology Business Overview
        7.2.3 Diros Technology Tumor Radiofrequency Ablation Introduction
        7.2.4 Diros Technology Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.2.5 Diros Technology Recent Development
    7.3 Halyard Health
        7.3.1 Halyard Health Company Details
        7.3.2 Halyard Health Business Overview
        7.3.3 Halyard Health Tumor Radiofrequency Ablation Introduction
        7.3.4 Halyard Health Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.3.5 Halyard Health Recent Development
    7.4 St. Jude Medical
        7.4.1 St. Jude Medical Company Details
        7.4.2 St. Jude Medical Business Overview
        7.4.3 St. Jude Medical Tumor Radiofrequency Ablation Introduction
        7.4.4 St. Jude Medical Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.4.5 St. Jude Medical Recent Development
    7.5 Cosman Medical
        7.5.1 Cosman Medical Company Details
        7.5.2 Cosman Medical Business Overview
        7.5.3 Cosman Medical Tumor Radiofrequency Ablation Introduction
        7.5.4 Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.5.5 Cosman Medical Recent Development
    7.6 Medtronic
        7.6.1 Medtronic Company Details
        7.6.2 Medtronic Business Overview
        7.6.3 Medtronic Tumor Radiofrequency Ablation Introduction
        7.6.4 Medtronic Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.6.5 Medtronic Recent Development
    7.7 NeuroTherm
        7.7.1 NeuroTherm Company Details
        7.7.2 NeuroTherm Business Overview
        7.7.3 NeuroTherm Tumor Radiofrequency Ablation Introduction
        7.7.4 NeuroTherm Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.7.5 NeuroTherm Recent Development
    7.8 Stryker
        7.8.1 Stryker Company Details
        7.8.2 Stryker Business Overview
        7.8.3 Stryker Tumor Radiofrequency Ablation Introduction
        7.8.4 Stryker Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.8.5 Stryker Recent Development
    7.9 Cosman Medical
        7.9.1 Cosman Medical Company Details
        7.9.2 Cosman Medical Business Overview
        7.9.3 Cosman Medical Tumor Radiofrequency Ablation Introduction
        7.9.4 Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2017-2022)
        7.9.5 Cosman Medical Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Tumor Radiofrequency Ablation Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Tumor Radiofrequency Ablation Market Trends
    Table 3. Tumor Radiofrequency Ablation Market Drivers
    Table 4. Tumor Radiofrequency Ablation Market Challenges
    Table 5. Tumor Radiofrequency Ablation Market Restraints
    Table 6. Global Tumor Radiofrequency Ablation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Tumor Radiofrequency Ablation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Tumor Radiofrequency Ablation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Tumor Radiofrequency Ablation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Tumor Radiofrequency Ablation Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Tumor Radiofrequency Ablation Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Tumor Radiofrequency Ablation Revenue Share by Player, 2017-2022
    Table 13. Global Tumor Radiofrequency Ablation Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Tumor Radiofrequency Ablation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Radiofrequency Ablation as of 2021)
    Table 15. Top Players of Tumor Radiofrequency Ablation in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Tumor Radiofrequency Ablation Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Tumor Radiofrequency Ablation Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Tumor Radiofrequency Ablation Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Tumor Radiofrequency Ablation Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Tumor Radiofrequency Ablation Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Tumor Radiofrequency Ablation Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Tumor Radiofrequency Ablation Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Tumor Radiofrequency Ablation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Tumor Radiofrequency Ablation Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Tumor Radiofrequency Ablation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Tumor Radiofrequency Ablation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Tumor Radiofrequency Ablation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Boston Scientific Company Details
    Table 31. Boston Scientific Business Overview
    Table 32. Boston Scientific Tumor Radiofrequency Ablation Product
    Table 33. Boston Scientific Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 34. Boston Scientific Recent Development
    Table 35. Diros Technology Company Details
    Table 36. Diros Technology Business Overview
    Table 37. Diros Technology Tumor Radiofrequency Ablation Product
    Table 38. Diros Technology Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 39. Diros Technology Recent Development
    Table 40. Halyard Health Company Details
    Table 41. Halyard Health Business Overview
    Table 42. Halyard Health Tumor Radiofrequency Ablation Product
    Table 43. Halyard Health Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 44. Halyard Health Recent Development
    Table 45. St. Jude Medical Company Details
    Table 46. St. Jude Medical Business Overview
    Table 47. St. Jude Medical Tumor Radiofrequency Ablation Product
    Table 48. St. Jude Medical Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 49. St. Jude Medical Recent Development
    Table 50. Cosman Medical Company Details
    Table 51. Cosman Medical Business Overview
    Table 52. Cosman Medical Tumor Radiofrequency Ablation Product
    Table 53. Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 54. Cosman Medical Recent Development
    Table 55. Medtronic Company Details
    Table 56. Medtronic Business Overview
    Table 57. Medtronic Tumor Radiofrequency Ablation Product
    Table 58. Medtronic Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 59. Medtronic Recent Development
    Table 60. NeuroTherm Company Details
    Table 61. NeuroTherm Business Overview
    Table 62. NeuroTherm Tumor Radiofrequency Ablation Product
    Table 63. NeuroTherm Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 64. NeuroTherm Recent Development
    Table 65. Stryker Company Details
    Table 66. Stryker Business Overview
    Table 67. Stryker Tumor Radiofrequency Ablation Product
    Table 68. Stryker Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 69. Stryker Recent Development
    Table 70. Cosman Medical Company Details
    Table 71. Cosman Medical Business Overview
    Table 72. Cosman Medical Tumor Radiofrequency Ablation Product
    Table 73. Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2017-2022) & (US$ Million)
    Table 74. Cosman Medical Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tumor Radiofrequency Ablation Product Picture
    Figure 2. Global Tumor Radiofrequency Ablation Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Tumor Radiofrequency Ablation Market Size 2017-2028 (US$ Million)
    Figure 4. United States Tumor Radiofrequency Ablation Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Tumor Radiofrequency Ablation Market Size 2017-2028 (US$ Million)
    Figure 6. United States Tumor Radiofrequency Ablation Market Share in Global 2017-2028
    Figure 7. Tumor Radiofrequency Ablation Report Years Considered
    Figure 8. Product Picture of Lung Cancer
    Figure 9. Product Picture of Kidney Cancer
    Figure 10. Product Picture of Breast Cancer
    Figure 11. Product Picture of Prostate Cancer
    Figure 12. Product Picture of Liver Cancer
    Figure 13. Product Picture of Others
    Figure 14. Global Tumor Radiofrequency Ablation Market Share by Type in 2022 & 2028
    Figure 15. Global Tumor Radiofrequency Ablation Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Tumor Radiofrequency Ablation Market Share by Type (2017-2028)
    Figure 17. United States Tumor Radiofrequency Ablation Market Share by Type in 2022 & 2028
    Figure 18. United States Tumor Radiofrequency Ablation Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Tumor Radiofrequency Ablation Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Cancer Specialty Clinics
    Figure 22. Product Picture of Others
    Figure 23. Global Tumor Radiofrequency Ablation Market Share by Application in 2022 & 2028
    Figure 24. Global Tumor Radiofrequency Ablation Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Tumor Radiofrequency Ablation Market Share by Application (2017-2028)
    Figure 26. United States Tumor Radiofrequency Ablation Market Share by Application in 2022 & 2028
    Figure 27. United States Tumor Radiofrequency Ablation Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Tumor Radiofrequency Ablation Market Share by Application (2017-2028)
    Figure 29. North America Tumor Radiofrequency Ablation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Tumor Radiofrequency Ablation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Tumor Radiofrequency Ablation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Tumor Radiofrequency Ablation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Tumor Radiofrequency Ablation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Tumor Radiofrequency Ablation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Boston Scientific Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 58. Diros Technology Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 59. Halyard Health Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 60. St. Jude Medical Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 61. Cosman Medical Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 62. Medtronic Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 63. NeuroTherm Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 64. Stryker Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 65. Cosman Medical Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific
Diros Technology
Halyard Health
St. Jude Medical
Cosman Medical
Medtronic
NeuroTherm
Stryker
Cosman Medical
Frequently Asked Questions
Tumor Radiofrequency Ablation report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tumor Radiofrequency Ablation report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tumor Radiofrequency Ablation report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports